EHI
PRAX icon

Eagle Health Investments’s Praxis Precision Medicines PRAX Stock Holding History

Eagle Health Investments’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,951
Closed -$4.41M – 34
2025
Q4 		$4.41M Buy
+14,951
New +$2.78M 0.97% 23

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Eagle Health Investments's PRAX Position: Q1 2026 in Review

Eagle Health Investments sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 14,951 shares — an estimated $4.41M sold.

Eagle Health Investments first reported a position in PRAX in Q4 2025 and held it in 1 quarter. The position peaked at $4.41M in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Eagle Health Investments reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
  • Eagle Health Investments sold 14,951 Praxis Precision Medicines shares in Q1 2026, an estimated $4.41M.
  • Eagle Health Investments first reported a position in Praxis Precision Medicines in Q4 2025 and held it in 1 quarter.
  • Eagle Health Investments's Praxis Precision Medicines position peaked at $4.41M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.